FDA 483 - Norwich Pharmaceuticals, Inc. - March 16, 2021
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of Norwich Pharmaceuticals, Inc. in Norwich, NY, identified significant deficiencies related to equipment cleaning procedures and equipment qualification. The firm lacked detailed cleaning instructions, proper cleaning verification, and formal cleaning validation, and failed to adequately qualify critical manufacturing and checkweighing equipment for its intended commercial use. These observations indicate a need for improved adherence to Good Manufacturing Practices.
ID · d37e5546-1a9e-48fd-9763-4526e8f15053